| Product NDC: | 25021-662 |
| Proprietary Name: | rocuronium bromide |
| Non Proprietary Name: | rocuronium bromide |
| Active Ingredient(s): | 10 mg/mL & nbsp; rocuronium bromide |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25021-662 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091458 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111220 |
| Package NDC: | 25021-662-10 |
| Package Description: | 10 VIAL in 1 CARTON (25021-662-10) > 10 mL in 1 VIAL |
| NDC Code | 25021-662-10 |
| Proprietary Name | rocuronium bromide |
| Package Description | 10 VIAL in 1 CARTON (25021-662-10) > 10 mL in 1 VIAL |
| Product NDC | 25021-662 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rocuronium bromide |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20111220 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | ROCURONIUM BROMIDE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |